C.F.R. » Title 21 » CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES › SUBCHAPTER D—DRUGS FOR HUMAN USE › PART 358—MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE › Subpart G—Pediculicide Drug Products

21 C.F.R. § 358.603

Definition

Read at: eCFRecfr.gov CornellLII GovInfogovinfo.gov CasesGoogle Scholar

As used in this subpart:

Pediculicide drug product. A drug product for the treatment of head, pubic (crab), and body lice.

Notes of Decisions
Cited in 3 cases, 2003–2008 · leading case: Warner-Lambert Co. v. Mills, 117 S.W.3d 488 (Tex. App. 2003).
Sort: Relevance Newest Treatment
Warner-Lambert Co. v. Mills, 117 S.W.3d 488 (Tex. App. 2003). · cites it 2× “" 21 C.F.R. § 358.603 . [2] What is not before us and we are not deciding is any claim or allegation that a particular nonprescription pediculicide does not contain the FDA-approved active ingredients: "the combination of pyrethrum extract (providing a concentration of…”
Mills v. Warner-Lambert Co., 581 F. Supp. 2d 772 (E.D. Tex. 2008). “” ” 21 C.F.R. § 358.603 . 6 . The FDCA contains another preemption provision in 21 U.”
Warner-Lambert Co., Pfizer, Inc., Bayer Corp., Del Pharm., Inc., Del Labs., Inc. & Care Tech., Inc. v. Katherine Mills & Veronica Evans, Individually & on Behalf of All Others Similarly Situated (Tex. App. 2003). “" 21 C.F.R. § 358.603 . 2. What is not before us and we are not deciding is any claim or allegation that a particular nonprescription pediculicide does not contain the FDA-approved active ingredients: "the combination of pyrethrum extract (providing a concentration of pyrethrins…”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.